(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted ...
Elevance Health (NYSE:ELV – Free Report) had its price target upped by Barclays from $501.00 to $512.00 in a report published on Friday,Benzinga reports. The firm currently has an overweight rating on ...